Our field is continually evolving in terms of diagnostic, interventional, therapeutic procedures and patient care.

Welcome

CathLab.com recognizes that today’s cardiac and vascular professionals are working in a field that is continually evolving in terms of diagnostic, interventional, therapeutic procedures and patient care. New products and technologies are introduced and adopted every day. As a result, there is a need for a site dedicated solely to the non-physician professional, which provides in-depth coverage on current topics. Our site is designed for cardiac and vascular nurses, technologists, educators, managers, and directors, sharing the latest product insights, news, and education on one website.

News

Malpractice cases serve to warn about careful use of EHRs

“I hear that a lot, but am not rushing out to get one. Yes, I have an EHR, but it’s one I designed myself. It works very well for my dinky little practice, and I’m happy with it.
I get notes from practices that use commercial EHRs all the time. They’re usually a pile of gobbledygook, mixing labs, vital signs, medication lists, and ICD-10 codes that tell you absolutely nothing about the patient or the physician’s thought process.”

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

“AUDIENCE: Surgery, Risk Manager ISSUE: The FDA has recently received multiple adverse event reports associated with Baxter International Inc.’s Vascu-Guard Peripheral Vascular Patch (also referred to as the Vascu-Guard patch) during carotid endarterectomy (CEA).”

Short-term DAPT Not Necessarily the Best Option for All, Especially After Complex PCI

“Much of the conversation around individualizing decisions on dual antiplatelet therapy (DAPT) duration after PCI has focused on clinical parameters, but a new study presented Monday at the European Society of Cardiology (ESC) Congress 2016 advocates integrating anatomical factors in order to more precisely prevent adverse outcomes.”

Does Optical Coherence Tomography Optimize Results of Stenting

“The goal of the trial was to assess the efficacy of optical coherence tomography (OCT) in optimizing percutaneous coronary intervention (PCI) among patients with non–ST-segment elevation acute coronary syndromes (NSTE-ACS).”

esensialcare
max
lumedex
barcare
life
axis